logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
Market PulseMarket Pulse
ScreenersScreeners
MoreMore
prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
Medplus Health Services Ltd

Medplus Health Services

Mid Cap•23,415 Employees•IPO 2021
Current Price
₹815.00
-24.85 (-2.96%)Updated
NSE :MEDPLUS
BSE :543427
Sector :Consumer Staples Distribution & Retail
Today's Range
₹810.00
₹815.00
union icon
₹839.75
52 Week Range
52W Low₹678.05
52W High₹1045.30
₹815.00
union icon
Downside20.20%
Upside28.26%
chart iconChart

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
₹10,199.24 Cr
Market Cap
Total market value of company
P/E Ratio
49.13
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
4.92
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
₹17.25
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
5.96%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
10.30%
ROCE
Return on Capital Employed. >15% is good
Net Margin
3.17%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
132.92%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
16.41%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
3.61%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
195.00%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
0.64
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
₹145.42
Book Value
Net asset value per share
Dividend Yield
-%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
40.30%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

4 points
  • •Medplus reported a remarkable 195% increase in quarterly profit (PAT of 42.4 Cr), alongside a 3.61% rise in quarterly sales, indicating robust operational efficiency and growing market demand.
  • •The company exhibits a healthy Return on Equity (ROE) of 8.80%, suggesting efficient utilization of shareholder funds to generate profits, which is a positive sign for investors.

Weaknesses

4 points
  • •Medplus's P/E ratio of 50.50 is significantly higher than its peer Entero Healthcare (47.01) and the sector P/E of 71.44, suggesting potential overvaluation and higher investment risk.
  • •The company carries a debt-to-equity ratio of 0.64, indicating a notable level of debt that could constrain financial flexibility and potentially impact profitability during economic downturns.

Opportunities

4 points
  • •The "Pharmacy Retail" industry, where Medplus operates, is likely to see continued expansion driven by increasing healthcare awareness, rising disposable incomes, and urbanization.
  • •The growing trend of digitalization and e-pharmacy platforms presents a significant opportunity for Medplus to expand its reach, enhance customer convenience, and drive sales growth.

Threats

4 points
  • •The pharmacy retail sector faces intense competition from both organized players like Entero Healthcare and unorganized local pharmacies, potentially impacting Medplus's market share and pricing power.
  • •The highly regulated pharmaceutical industry is susceptible to policy changes, such as drug pricing controls or new licensing requirements, which could negatively affect Medplus's operations and profitability.

Segment-wise Financial Analysis

Financial Results

Balance Sheet

Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format

No Balance Sheet Data Available

Standalone annual data is not available for this symbol.
Try switching to Consolidated view.

Shareholding Pattern

Loading shareholding data...

Company Insider Trading Activity

Recent Insider Transactions

Insider NameTransaction DateFiling DateTotal SharesChangePriceAction
MADHUKAR REDDY GANGADI
23 Dec 202424 Dec 20241.54 Cr
1.34 Cr
₹865.75BUY
Lone Furrow Investment Private Limited
27 Dec 202430 Dec 20241.72 Cr
1.54 Cr
₹839.15BUY
Lone Furrow Investment Private Limited
02 Jan 202503 Jan 20251.72 Cr
5.00 L
₹831.75BUY
MADHUKAR REDDY GANGADI
31 Dec 202403 Jan 20251.54 Cr
19.18 L
₹847.2BUY

Corporate Action

Company Announcements

Technical Analysis & Indicators

Standard pivot points - most widely used

Pivot Points (CLASSIC)

LevelPriceDistance% Change
R4₹892.67+₹77.67+9.53%
R3₹862.92+₹47.92+5.88%
R2₹851.33+₹36.33+4.46%
R1₹833.17+₹18.17+2.23%
PIVOT₹821.586.580.81%
CURRENT₹815.00--
S1₹743.92-₹71.08-8.72%
S2₹773.67-₹41.33-5.07%
S3₹791.83-₹23.17-2.84%
S4₹803.42-₹11.58-1.42%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: N/AP: N/ATC: N/A
R1
R2
R3
R4
indicator
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment

is trading CPR, indicating

● CPR Width

CPR is

● Opening Range

Day's range: ~

● Price Position

Trading Inside opening range

Delivery Volume Analysis & Trading Activity

Latest Volume
1.74L
(04 Mar 2026)
-0.3% vs avg
Delivery %
59.8%
(04 Mar 2026)
-5.5% vs avg
Avg Volume (20D)
1.74L
(04 Feb - 04 Mar)
20-day average
Avg Delivery %
65.3%
(04 Feb - 04 Mar)
Trend ↑
Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

Peer Comparison & Industry Benchmarking

No peer comparison data available

About

MEDPLUS

Medplus Health Services Ltd

MedPlus Health Services Limited is a prominent Indian company primarily engaged in the retail sale of pharmaceuticals and a wide range of related products. Their business model centers around a vast network of physical stores strategically located across several key Indian states, including Telangana, Andhra Pradesh, Karnataka, Tamil Nadu, West Bengal, Maharashtra, Orissa, Madhya Pradesh, Chhattisgarh, Kerala, and Puducherry. This extensive physical presence allows them to reach a large customer base and offer convenient access to essential healthcare items.

Beyond retail sales, MedPlus has diversified its operations to include the manufacturing and trading of both pharmaceutical and wellness products. This encompasses a substantial portfolio, ranging from prescription medications and vitamins to medical devices and diagnostic test kits. The company's product line also extends into the consumer goods sector, with a focus on home and personal care items such as toiletries, baby care products, soaps, detergents, and sanitizers. This diversification strengthens their market position and allows them to cater to a broader range of consumer needs within the health and wellness space.

Further expanding their reach and services, MedPlus operates a robust wholesale cash-and-carry business, supplying pharmaceuticals and related goods to other businesses and healthcare providers. In addition to retail and wholesale, MedPlus offers a range of healthcare services including diagnostic, pathological, and laboratory testing services. This integrated approach to healthcare allows them to provide a comprehensive suite of offerings under a single brand, enhancing customer convenience and loyalty.

The company also undertakes contract manufacturing of private label pharmaceuticals for other companies, demonstrating their capabilities in production and supply chain management. The addition of an online platform complements their physical store network, enhancing accessibility and reach to customers across various geographical locations. In summary, MedPlus' business model is characterized by a strategic combination of retail sales, manufacturing, wholesale distribution, healthcare services, and an online presence, solidifying its position as a significant player in India's healthcare market.

COMPANY FACTS - MEDPLUS

Registered Address

H. No: 11-6-56, Survey No: 257 & 258/1,, Opp: IDPL Railway Siding Road, Moosapet,, Kukatpally

Hyderabad

TELANGANA

IN

Tel: 914067006700

Website:https://www.medplusindia.com/

Company Details

Group: Consumer Staples Distribution & Retail

Sector: Consumer Staples

Industry: Consumer Staples Distribution & Retail

Exchange: NATIONAL STOCK EXCHANGE OF INDIA

Employees: 23,415

IPO Date: 23/12/2021

MANAGEMENT - MEDPLUS

Mr. Gangadi Reddy

Executive Chairman of the Board, Chief Executive Officer, Managing Director

Mr. Sujit Mahato

Chief Financial Officer

Dr. Cherukupalli Reddy

Chief Operating Officer, Whole-time Director

Mr. Subrahmanyam Tatapudi

Chief Technology Officer

Mr. Manoj Srivastava

Head-Corporate Secretarial, Governance, Company Secretary, Compliance Officer

Mr. Kandasamy Vairaperumal

Head of Supply Chain

Mr. Anish Saraf

Non-Executive Director

Mr. Madhavan Ganesan

Non-Executive Independent Director

Mr. Thyagarajan Muralidharan

Additional Non-Executive Independent Director

Mr. Murali Sivaraman

Non-Executive Independent Director

Ms. Aparna Surabhi

Additional Non-Executive Independent Director

Investor Questions Answered

Medplus Health Services Ltd (MEDPLUS) Stock FAQs

Get answers to the most common questions about Medplus Health Services Ltd stock price, fundamentals, financial metrics, and investment analysis

The current share price of Medplus Health Services Ltd (MEDPLUS) is ₹815. Today, the stock has declined by ₹24.85 (2.96%), trading in a range of ₹810 to ₹839.75. The stock opened at ₹839.75 with a trading volume of 1,73,537 shares.
Medplus Health Services Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹10,199.24 crores, P/E ratio of 49.13, ROE of 5.96%, and ROCE of 10.30%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Medplus Health Services Ltd (MEDPLUS) is ₹1,045.3, while the 52-week low is ₹678.05. Currently trading at ₹815, the stock is 37.3% away from its 52-week low and 22.0% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Medplus Health Services Ltd stock at ₹815 depends on multiple factors. The stock is currently trading with a P/E ratio of 49.13 and P/B ratio of N/A. Today's performance shows a loss of 2.96%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Medplus Health Services Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹815, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Medplus Health Services Ltd's key financial metrics include: P/E Ratio: 49.13, P/B Ratio: N/A, ROE: 5.96%, ROCE: 10.30%, Dividend Yield: 0.00%, EPS: ₹17.25, Book Value: ₹145.42, Debt-to-Equity: 0.64, and Current Ratio: N/A. The company's market cap stands at ₹10,199.24 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Medplus Health Services Ltd stock opened at ₹839.75 and is currently trading at ₹815, showing a decline of ₹24.85 (2.96%). The intraday high is ₹839.75 and low is ₹810. The trading volume stands at 1,73,537 shares, indicating moderate market participation today.
Medplus Health Services Ltd has a Price-to-Earnings (P/E) ratio of 49.13, which means investors are willing to pay ₹49.13 for every ₹1 of earnings. With an EPS of ₹17.25, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
Medplus Health Services Ltd has a market capitalization of ₹10,199.24 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹815) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Medplus Health Services Ltd has a book value of ₹145.42 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹815, which is 460.4% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Medplus Health Services Ltd has a Return on Equity (ROE) of 5.96% and Return on Capital Employed (ROCE) of 10.30%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Medplus Health Services Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Medplus Health Services Ltd has a debt-to-equity ratio of 0.64, which measures the company's financial leverage by comparing total debt to shareholders' equity. This moderate ratio indicates balanced use of debt and equity. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Medplus Health Services Ltd has an Earnings Per Share (EPS) of ₹17.25, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹815 and P/E ratio of 49.13, investors are paying 49.13 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Medplus Health Services Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Medplus Health Services Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Medplus Health Services Ltd stock, consider: 1) Fundamental Analysis - Review P/E (49.13), ROE (5.96%), debt-to-equity (0.64), and growth rates. 2) Technical Analysis - Check 52-week range (₹678.05 - ₹1045.30), moving averages, and chart patterns. 3) Valuation - Compare current price (₹815.00) with book value (₹145.42) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Medplus Health Services Ltd share is ₹2.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹815 is 40650x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Medplus Health Services Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹678.05 - ₹1045.30). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.64 indicates leverage. 4) Liquidity Risk - Based on trading volume of 1,73,537 shares. 5) Valuation Risk - P/E of 49.13 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Medplus Health Services Ltd operates in the industry with key metrics: P/E ratio of 49.13, ROE of 5.96%, market cap of ₹10,199.24 crores, and dividend yield of 0.00%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.64), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Medplus Health Services Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹815, with a 52-week range of ₹678.05 to ₹1045.30. Based on fundamentals like P/E (49.13), ROE (5.96%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Medplus Health Services Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹815.00. 2) Fundamental Deterioration - Declining ROE (currently 5.96%), increasing debt (D/E: 0.64), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Medplus Health Services Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.00%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.